Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 11369 - 11376 of 12141 results

Wage and Hour Considerations and Inclement Weather: In the Wake of Hurricane Sandy
November 6, 2012| Blog| Viewpoint

California's AG Puts Mobile Apps on Notice
November 6, 2012| Blog| Viewpoint

New York Employers May Not Seek to Prevent Their Employees From Voting or Attempt to Improperly Influence Their Votes
November 5, 2012| Blog| Viewpoint

Commercial Landlords Seek Share of Tenants' Online Sales
November 4, 2012| News

2013 Medicare Physician Fee Schedule: Issues of Interest to Independent Laboratories
November 2, 2012| Blog| Viewpoint

The FTC Fires Back Against Wyndham
November 2, 2012| Blog| Viewpoint

Google and Rosetta Stone Settle AdWords Trademark Infringement Suit
October 31, 2012| Blog| Viewpoint

Section 409A Document Correction Relief: Take the Final Bite of the Apple before December 31st
October 30, 2012| Blog| Viewpoint
News & Press Releases
Mintz Advises Point72 and Tsunami Express Car Wash in Acquisition of 53 Car Wash Locations from Whistle Express Car Wash
September 16, 2025
Mintz advised Point72 and Tsunami Express Car Wash, its portfolio company, in Tsunami’s acquisition of 53 car wash locations from Whistle Express Car Wash, which is owned by affiliates of Oaktree Capital Management.
Mintz Advises Charlesbank Capital Partners on Acquisition of Q6 Cyber
September 15, 2025
Mintz Advises on LB Pharmaceuticals’ $285 Million Initial Public Offering
September 12, 2025
Mintz advised the underwriters in connection with a $285 million initial public offering by LB Pharmaceuticals Inc of 19,000,000 shares of common stock at an initial public offering price of $15.00 per share. The aggregate gross proceeds to LB Pharmaceuticals from this offering were approximately $285 million before deducting underwriting discounts and commissions and other offering expenses. In addition, LB Pharmaceuticals granted the underwriters a 30-day option to purchase up to an additional 2,850,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The shares began trading on the Nasdaq Global Market on September 11, 2025 under the ticker symbol “LBRX.”
Events
Podcasts

Mintz On Air: Practical Policies – DEI Developments: The Proxy Problem
September 16, 2025| Podcast|

Mintz On Air: Practical Policies – Disparage Me Not
August 26, 2025| Podcast|

Mintz On Air: Practical Policies - Investigations Unscripted
August 12, 2025| Podcast|
